resveratrol has been researched along with diethylnitrosamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhardwaj, A; Kaushik, G; Khanduja, KL | 1 |
| Bishayee, A; Dhir, N | 1 |
| Barnes, KF; Bhatia, D; Bishayee, A; Chatterjee, M; Darvesh, AS; Mbimba, T; Waghray, A | 1 |
| Barnes, KF; Bhatia, D; Bishayee, A; Carroll, RT; Darvesh, AS | 1 |
| Awale, P; Bhatia, D; Bishayee, A; Carroll, RT; Darvesh, AS; Geldenhuys, WJ; Mbimba, T | 1 |
| Ma, ST; She, SF; Xiong, YY; Yu, H; Zhang, XL; Zhao, L | 1 |
6 other study(ies) available for resveratrol and diethylnitrosamine
| Article | Year |
|---|---|
Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Diethylnitrosamine; Enzyme Induction; Liver; Lung; Male; Mice; Mice, Inbred BALB C; Microsomes; Ornithine Decarboxylase; Prostaglandin-Endoperoxide Synthases; Resveratrol; Stilbenes | 2004 |
Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Body Weight; Cell Proliferation; Diethylnitrosamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking; Drug Screening Assays, Antitumor; Eating; Female; Immunohistochemistry; Liver Neoplasms, Experimental; Organ Size; Phenobarbital; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2009 |
Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Chemoprevention; Cyclooxygenase 2; Diethylnitrosamine; Female; HSP70 Heat-Shock Proteins; Humans; Inflammation; Liver; Liver Neoplasms; NF-kappa B; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2010 |
Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis.
Topics: Animals; Antioxidants; Carcinogens; Chemical and Drug Induced Liver Injury; Diethylnitrosamine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Induction; Female; Hyperplasia; Inflammation; Lipid Peroxidation; Liver; Liver Neoplasms, Experimental; NF-E2-Related Factor 2; Nitric Oxide Synthase Type II; Oxidative Stress; Phenobarbital; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes; Tyrosine | 2010 |
Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Cytokines; Diethylnitrosamine; Female; Gene Expression Regulation; Liver; Liver Neoplasms, Experimental; Phenobarbital; Rats; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes | 2012 |
Resveratrol down-regulates Myosin light chain kinase, induces apoptosis and inhibits diethylnitrosamine-induced liver tumorigenesis in rats.
Topics: Alkylating Agents; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Diethylnitrosamine; Down-Regulation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Liver Neoplasms, Experimental; Male; Myosin-Light-Chain Kinase; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2013 |